Mealey's (November 20, 2018, 4:35 PM EST) -- WILMINGTON, Del. — A Delaware Superior Court jury on Nov. 7 found that a pharmaceutical company and its co-founders misappropriated its competitor’s trade secret information pertaining to the development of a cancer treatment drug but rejected the competitor’s allegations that the drug maker was unjustly enriched because of the misappropriation (Incyte Corp. v. Flexus Biosciences Inc., et al., No. N15C-09-055 MMJ (CCLD), Del. Super.)....